Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
1.2780
-0.0080
(-0.62%)
As of 8:09:45 AM GMT+1. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
62,753
-24,746
-87,444
-104,562
-80,261
Investing Cash Flow
-99,799
-15,510
-2,761
7,279
-54,342
Financing Cash Flow
127,768
82,865
1,145
47,525
27,321
End Cash Position
158,078
136,708
93,216
185,636
241,148
Capital Expenditure
-2,374
-1,073
-2,441
-18,556
-44,423
Issuance of Capital Stock
127,145
67,936
--
44,638
9,205
Issuance of Debt
17,706
29,671
5,750
--
24,170
Repayment of Debt
-16,349
-16,191
-12,354
-10,641
-4,737
Repurchase of Capital Stock
-469
--
-569
--
--
Free Cash Flow
60,379
-25,819
-89,885
-123,118
-124,684
12/31/2020 - 2/20/2007
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
BV3A.F Bavarian Nordic A/S
7.20
-3.36%
22Z.F Zealand Pharma A/S
76.70
-5.47%
4R0.F Oxford Nanopore Technologies plc
1.1140
-13.24%
AYJ.F Valneva SE
3.2680
-3.88%
CVAC CureVac N.V.
3.0150
-2.11%
RVMD Revolution Medicines, Inc.
37.48
-2.24%
MESO Mesoblast Limited
14.32
-7.07%
ALNY Alnylam Pharmaceuticals, Inc.
238.94
-1.89%
AXSM Axsome Therapeutics, Inc.
123.25
-3.07%
REGN Regeneron Pharmaceuticals, Inc.
688.92
+0.59%